Downloaded from: justpaste.it/1pa4b
Covaxin supply suspension by WHO not to impact
travel by people: MEA
WHO suspending the supply of Covaxin through UN procurement agencies over
“process and facility upgrade” requirements will not have an impact on travel
World Health Organization (WHO) suspending the supply of
Covaxin through UN procurement agencies over “process and
facility upgrade” requirements will not have an impact on travel by
those who have taken the COVID vaccine, Ministry of External
Affairs said on Thursday.
Answering a query about the impact on people travelling abroad
due to the present suspension of Covaxin supplies, MEA
spokesperson Arindam Bagchi said that in terms of their travel, the
vaccine continues to be recognized under the emergency use
listing of WHO and various countries have already accepted it.
“I think there has been a statement issued by Bharat Biotech as
well as from WHO, both of which are very clear in emphasizing
that the vaccine is safe, its effective. Its efficacy is not in question,”
Bagchi said at the regular media briefing. “There is something
about process issues that are being worked out between the
company and WHO. You will have to ask them about the details,”
he added.